Inter Parfums Upgraded to Outperform at Zacks (IPAR)

Zacks upgraded shares of Inter Parfums (NASDAQ: IPAR) from a neutral rating to an outperform rating in a research note issued to investors on Friday. The firm currently has $25.80 target price on the stock.

A number of other firms have also recently commented on IPAR. Analysts at B. Riley upgraded shares of Inter Parfums from a neutral rating to a buy rating in a research note to investors on Thursday, January 31st. They now have a $27.00 price target on the stock. Separately, analysts at upgraded shares of Inter Parfums from a neutral rating to a buy rating in a research note to investors on Thursday, January 31st. They now have a $27.00 price target on the stock, up previously from $22.50. Finally, analysts at Citigroup reiterated a neutral rating on shares of Inter Parfums in a research note to investors on Wednesday, January 30th. They now have a $22.00 price target on the stock, up previously from $20.00.

Three investment analysts have rated the stock with a buy rating, one has issued an overweight rating, and three have issued a hold rating to the company’s stock. Inter Parfums currently has an average rating of overweight and a consensus price target of $24.17.

Inter Parfums traded up 4.96% on Friday, hitting $23.89. Inter Parfums has a 1-year low of $15.00 and a 1-year high of $24.00. The stock’s 50-day moving average is currently $21.64. The company has a market cap of $730.7 million and a price-to-earnings ratio of 19.62.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.



Latest News

Apple Tax Scandal can Lead to the Scrapping of Corporate Tax
Apple Tax Scandal can Lead to the Scrapping of Corporate Tax
Military Charges Soldier for Filming Female Cadets
Military Charges Soldier for Filming Female Cadets
Herbalife Employs PwC as Auditor
Herbalife Employs PwC as Auditor
Drug Resistant TB Bacteria Killed by Vitamin C
Drug Resistant TB Bacteria Killed by Vitamin C
AT&T Entering The Home Security Industry
AT&T Entering The Home Security Industry
Apple Avoids Billions via Tax Shelters
Apple Avoids Billions via Tax Shelters


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe